A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and is primarily characterised by a respiratory disease. However, SARS-CoV-2 can directly infect vascular endothelium and subsequently cause vascular inflammation, atherosclerotic p...
Guardado en:
Autores principales: | Stefanos Drakos, Grigorios Chatzantonis, Michael Bietenbeck, Georg Evers, Arik Bernard Schulze, Michael Mohr, Helena Fonfara, Claudia Meier, Ali Yilmaz |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/89af65b848f14659ab3f77e304c45c98 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CMR-based T1-mapping offers superior diagnostic value compared to longitudinal strain-based assessment of relative apical sparing in cardiac amyloidosis
por: Dennis Korthals, et al.
Publicado: (2021) -
Role of Inflammation in Coronary Epicardial and Microvascular Dysfunction
por: Shigeo Godo, et al.
Publicado: (2021) -
Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
por: Théo Pezel, et al.
Publicado: (2021) -
Markers for Inflammation and Oxidative Stress in Patients with Coronary Artery Disease and Microvascular Disease – Is there a Difference?
por: Cherneva Z., et al.
Publicado: (2019) - Microvascular research MVR.